BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 11, 2014
View Archived Issues
Protein-modified red blood cells engineered to deliver systemic payloads
Read More
Takeda Pharmaceutical reviews highlights of first quarter of fiscal 2014
Read More
Genetic modification of T-cell epitopes in therapeutic toxins to minimize immunogenic reactions
Read More
Valneva signs cell-line license agreement with GeoVax
Read More
Alvogen adds to Asian assets with acquisition of Dream Pharma
Read More
Mesoblast to collaborate with NIH on trial for stem cell therapy in heart failure
Read More
Cara Therapeutics initiates phase II trial of CR-845 in uremic pruritus
Read More
New Amsterdam Sciences studying NAS-911 as a co-therapeutic for influenza
Read More
Yabao Pharmaceuticals and Changzhou Le Sun Pharmaceuticals to develop oncology drug
Read More
New antisense oligonucleotides patented by Japanese group
Read More
Palobiofarma designs novel PDE10A inhibitors
Read More
Novo Nordisk offers overview of second quarter 2014
Read More
Leica Biosystems and Bristol-Myers Squibb collaborate on companion diagnostics
Read More
Novel agents for HCV infection disclosed by Bristol-Myers Squibb
Read More
Clinuvel declines Retrophin proposal
Read More
Novartis divulges novel Mdm2 and Mdm4 interaction inhibitors
Read More
OPKO Health submits IND for Rayaldee as an adjunctive cancer therapy
Read More
Trillium Therapeutics expands CD47 program into solid tumors
Read More
Chinese and U.S. researchers disclose novel antibacterial marinopyrrole derivatives
Read More
Oxygen Biotherapeutics confirms collaboration with Imperial College London
Read More
Baxter opens biologics facility with plans for expansion
Read More
FDA approves Invokamet for type 2 diabetes
Read More
Reversible non-peptide proteasome inhibitors as potential anticancer agents
Read More
Eylea approved in E.U. for DME
Read More
Daiichi Sankyo and Charleston Laboratories develop fixed-dose combination hydrocodone products
Read More
FDA approves Velcade for retreatment of multiple myeloma
Read More
Genentech files for U.S. approval of Lucentis for diabetic retinopathy
Read More